Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 1,750 | 1,750 | 1,562 | 4,291 | 1,250 |
| Gross Profit | 1,750 | 1,750 | 1,562 | 4,291 | 1,250 |
| Operating Expenses | 30,910 | 20,523 | 15,046 | 16,436 | 17,149 |
| Operating Income | -29,160 | -18,773 | -13,484 | -12,145 | -15,899 |
| Other Income | 1,070 | 1,103 | 1,189 | 1,333 | 2,366 |
| Pre-tax Income | -28,090 | -17,670 | -12,295 | -10,812 | -13,533 |
| Net Income Continuous | -28,090 | -17,670 | -12,295 | -10,812 | -13,533 |
| Net Income | $-28,090 | $-17,670 | $-12,295 | $-10,812 | $-13,533 |
| EPS Basic Total Ops | -0.64 | -0.41 | 0.51 | -0.25 | -0.32 |
| EPS Basic Continuous Ops | -0.64 | -0.41 | 0.50 | -0.25 | -0.32 |
| EPS Diluted Total Ops | -0.64 | -0.41 | 0.51 | -0.25 | -0.32 |
| EPS Diluted Continuous Ops | -0.64 | -0.41 | 0.50 | -0.25 | -0.32 |
| EBITDA(a) | $-29,110 | $-18,567 | $-13,272 | $-12,188 | $-14,984 |